KRAZATI
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for KRAZATI, covering 2022-12-12 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Krazati (adagrasib) — Bristol-Myers Squibb Pharma EEIG